Using individual patient clinical values from patients 12 months prior to the confirmed diagnosis of HCC recurrence by imaging or biopsy, AFP and the Doylestown algorithm identified 18% and 59% of the recurrent HCC respectively (Table 7, p = 0.0021). The gene discussed is AFP; the disease is hepatocellular carcinoma.